Articles + Publications August 20, 2025
Export Control Transparency Act: Words of Caution
Yesterday, President Trump signed into law the Export Control Transparency Act. While this new law includes a confidentiality provision, organizations submitting export license applications to the Commerce Department’s Bureau of Industry and Security (BIS) should, in some cases, be concerned about the implications.
For certain types of license requests, the name of the applicant, end user, type of product/technology, value, and other details will be reported to Congress. In many cases, this information is quite sensitive. For example, suppliers may not be aware that their products are being exported to restricted end users, and may object to this (even if fully lawful), jeopardizing supply chains. Banks and other partners may increase scrutiny. Valuations on export license applications can be misleading and may give rise to hard questions. Of course, outside attention to business with restricted parties is typically not desirable, and companies probably won’t be able to provide the proper context to explain the information being reported.
Therefore, a major looming question for organizations within this law’s scope is the likelihood that members of Congress or their staff may publicly disclose the information that is reported to them or otherwise use it in unintended ways. Many organizations will not be comfortable with this risk and will look for alternative strategies. Some may reconsider opportunities to remove their exports from BIS’s licensing jurisdiction. As a result, this law may further discourage U.S. exports and add another incentive for offshoring, reducing U.S. sourcing, etc.
However, the narrow scope of the law is helpful. It only covers applications for export, transfer, etc. “to covered entities,” which must be both: 1) located in a U.S. arms-embargoed country (e.g., China), and 2) on the BIS Military End-User List or Entity List. With this in mind, only a tiny proportion of applications to BIS must be reported to Congress under this law.
If you have any questions about these developments, please contact a member of our Sanctions + Trade Controls team.
Insight Industries + Practices
Sponsored Events
Life Sciences Pennsylvania (LSPA) 2025 CEO & CFO Dinner
November 6, 2025
The Radnor Hotel – Triple Crown
593 E Lancaster Ave, Radnor, PA 19087
Sponsored Events
Orange County Business Journal 2025 General Counsel Awards
November 6, 2025 | 5:00 PM – 8:30 PM PT
Irvine Marriott
18000 Von Karman Ave., Irvine, CA 92612
Speaking Engagements
Restrictive Covenants in Virginia—An Update on the Law and Practice Tips for Drafting Enforceable Covenants
November 6, 2025 | 3:15 PM – 4:15 PM ET
Boar’s Head Resort
200 Ednam Drive, Charlottesville, VA 22930
Sponsored Events
2025 Developments in Pharmacy Law XXXVI Seminar
November 6 – 9, 2025
Westin Fort Lauderdale Beach Resort
321 N Fort Lauderdale Beach Blvd, Fort Lauderdale, FL 33304